InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
1
T+90 hit rate
36%
T+90 mean return
-2.5%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Hindman Andrew A., Chief Financial Officer. Insider active across 1 company, notably Theravance Biopharma, Inc.. Cumulatively, 13 filings have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €691k. Activity tracked since 20 May 2021. The latest transaction was disclosed on 18 November 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations13 total
65,000 shares@ US$11.019142.0% of flowOrdinary SharesSEC:0001415889-22-011671:0
25,676 shares@ US$9.3414.5% of flowOrdinary SharesSEC:0001415889-22-008983:0
20,000 shares0Ordinary SharesSEC:0001415889-22-008006:0
3,365 shares@ US$8.740.0033% mcap3.9% of flowOrdinary SharesSEC:0001415889-22-005631:0
25,973 shares@ US$9.610.026% mcap30.7% of flowOrdinary SharesSEC:0001415889-22-001699:0
340,000 shares0Ordinary SharesSEC:0001179110-21-010638
340,000 shares0Ordinary SharesSEC:0001179110-21-010638:0
1,350 shares@ US$8.360.0012% mcap1.4% of flowOrdinary SharesSEC:0001415889-21-005466:0
1,350 shares@ US$8.360.6% of flowOrdinary SharesSEC:0001415889-21-005466
17,464 shares@ US$14.0512.8% of flowOrdinary SharesSEC:0001179110-21-008394
17,464 shares@ US$14.050.025% mcap29.4% of flowOrdinary SharesSEC:0001179110-21-008394:0
942 shares@ US$17.801.9% of flowOrdinary SharesSEC:0001179110-21-005842
942 shares@ US$17.800.0016% mcap1.9% of flowOrdinary SharesSEC:0001179110-21-005842:0
13 of 13 declarations
About Hindman Andrew A.
Andrew A. Hindman is Senior Vice President and Chief Financial Officer at Theravance Biopharma, Inc. He is responsible for the financial management of the company, overseeing accounting and financial operations.
